All Type of News
KFDA formulates new rule concerning safety and efficacy of functional cosmetics
The Korea Food and Drug Administration announced it has enacted the new rule concerning safety and efficacy of functional cosmetic products that may ensure the efficacy of related cosmetics and bolster Korea's competi...
Yuhan Corporation targets pharmacy market
Yuhan Corporation, a leading pharmaceutical firm in Korea, is planning to implement "one-stop marketing" designed to supply a wide variety of OTC products to pharmacy via its existing outlets, as part of its efforts t...
KDRA: Drug discovery symposium
The Korea Drug Research Association (Chairman: Cho Ui-whan) plans to have the 3rd drug discovery symposium jointly with DI Biotech at Mariott hotel at 10 a.m. on Nov. 7 under the main theme of "Technology strategy in ...
MOHW to invite new healthcare medical technology promotion projects.
The MOHW announced to invite the new drug commercialization and development project as the 2nd new healthcare medical technology promotion programs covering the 2nd half of 2003.
The government supporting projects...
KHIDI's meeting for technology licensing and commercialization strategies.
The Health Industry Technology Transfer Center of the Korea Health Industry Development Institute (KHIDI) will have a conference at the conference room of aT Center (located at Yangjae dong Seocho-Ku, Seoul) from Dec....
National/public and private hospitals differ on purchase pattern of drugs
A recent study has shown that a great majority of national/public hospitals in Korea think that their top priority of selecting a drug is placed on its quality while private hospitals on its price, revealing the local...
Health Ministry set to establish new bureau and departments
Health and Welfare Minister Kim Hwa-joong said the ministry will newly set up a National Pension Deliberation Bureau and other three departments (Public Health and Medical Policy, Foreign Trade Cooperative Unit and Me...
Pharmaceutical firms concerned over results of drug price re-assessment
Domestic pharmaceutical industry expressed concern about possible fallout from the government's re-assessment work on drug prices, as it places more emphasis on the cutback of drug prices.
Following the recent comp...
MOHW revises list of non-reimbursable clinical tests
The Ministry of Health and Welfare unveiled its plan to extend the current insurance coverage to ten among 62 non-reimbursable clinical tests from January 1st 2004, while other tests including ultrasonography, MRI, ph...
NHI reimbursement prices likely to increase about 3% in 2004.
The MOHW and the NHIC are considering 3% price rise for the NHI reimbursement and 8% for the NHI premium in 2004.
In the NHI Policy Deliberation Council's meeting on Oct. 31 the MOHW suggested the next year insuran...
